Condition
Chronic Myeloid Leukemia, BCR/ABL-Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Myeloid Leukemia, BCR/ABL-Positive clinical trials that are recruiting, at sites in 2 countries (most in Taiwan (1), Spain (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Potential of asciminib in early chronic‑phase CML
This trial will see if asciminib alone, or asciminib plus nilotinib, helps adults newly diagnosed with chronic‑phase, BCR‑ABL–positive CML reach deep molecular responses and remain off treatment.
-
Evaluating treatment-free remission in chronic myeloid leukemia patients
This study is testing if adults with chronic myeloid leukemia can safely stop their medication after achieving strong treatment results for at least two years.
Related topics
Quick answers
How many Chronic Myeloid Leukemia, BCR/ABL-Positive clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Taiwan (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.